Quebec class action authorized against 16 pharma companies for role in opioid crisis – CBC
Lawsuit covers anyone who has been diagnosed with opioid use disorder since 1996
Apr 15, 2024
A class-action lawsuit has been authorized to proceed against 16 pharmaceutical companies for their role in manufacturing, selling, marketing and distributing opioid drugs in Quebec.
The lawsuit covers people who have been diagnosed with opioid use disorder since 1996, and their direct heirs if they are deceased.
That means there could be thousands of people in the province who could join the case, said Margo Siminovitch, with the Montreal-based firm Fishman Flanz Meland Paquin (FFMP).
“This was an important case to take on for our firm to really try to get justice for people harmed by the pharmaceutical industry who made millions of dollars off this medicine while downplaying the risks of opioids,” said Siminovitch.
Her firm is joining forces with Trudel Johnston and Lespérance, also based in Montreal, to pursue this case on behalf of a man from the Laurentians, Jean-François Bourassa.
Read more: https://www.cbc.ca/news/canada/montreal/montreal-class-action-quebec-opiod-1.7174493
